1,596 results match your criteria: "Keloid and Hypertrophic Scar"
Zhonghua Yu Fang Yi Xue Za Zhi
September 2024
Division of Spine Surgery, Department of Orthopedic Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210008, China.
Cancers (Basel)
August 2024
IDI-IRCCS, Dermatological Research Hospital, 00167 Rome, Italy.
Cureus
August 2024
Orthopedic Surgery, Holy Cross Hospital, Fort Lauderdale, USA.
J Biophotonics
November 2024
Amsterdam UMC, Location VUmc, Department of Plastic, Reconstructive and Hand Surgery, Amsterdam Movement Sciences, Amsterdam, The Netherlands.
Plast Reconstr Surg Glob Open
September 2024
From the Department of Plastic, Reconstructive and Aesthetic Surgery, Nippon Medical School, Tokyo, Japan.
Mol Med
September 2024
CIBER de enfermedades respiratorias, Health Institute Carlos III, Valencia, Spain.
J Cosmet Dermatol
November 2024
Plastic and Reconstructive Surgery & Burns, Affiliated Hospital of North Sichuan Medical College, Sichuan, Nanchong, China.
Ophthalmic Plast Reconstr Surg
August 2024
State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University.
J Am Acad Dermatol
December 2024
Division of Dermatology, Albert Einstein College of Medicine, Bronx, New York.
J Maxillofac Oral Surg
August 2024
Department of Oral & Maxillofacial Surgery, Government Dental College & Hospital, Ahmedabad, Gujarat India.
Front Med (Lausanne)
July 2024
Department of Dermatology, West China Hospital, Sichuan University, Chengdu, China.
Background: Recent advancements in basic medicine and epidemiology suggest a potential influence of blood pressure on scar formation, yet the specifics of this relationship are not fully understood. This study aims to clarify the causal link between blood pressure and the development of pathological scars using Mendelian randomization (MR).
Methods: This study employed genetic variants closely linked to blood pressure as instrumental variables to explore the relationship between blood pressure and pathological scars.
Arch Dermatol Res
August 2024
Department of Plastic Surgery, Vanderbilt University Medical Center, 1161 21st Ave S, Nashville, TN, USA.
Tissue Eng Regen Med
October 2024
Department of Plastic and Reconstructive Surgery, Yonsei University, 50-1 Yonsei-Ro, Seodaemun-Gu, Seoul, 03722, Korea.
Medicine (Baltimore)
August 2024
Department of Plastic and Reconstructive Surgery, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Cureus
June 2024
Department of Bone and Joint Surgery, Kawasaki Medical School, Okayama, JPN.
Int J Nanomedicine
July 2024
Department of Dermatology, Xiangya Hospital, Central South University, Changsha, 410008, People's Republic of China.
Front Med (Lausanne)
July 2024
Department of Dermatology, West China Hospital, Sichuan University, Chengdu, China.
Aesthetic Plast Surg
October 2024
School of Physics and Technology, Nantong University, NanTong, Jiangsu, China.
Urology
September 2024
James Buchanan Brady Urological Institute, Division of Pediatric Urology, Douglas A. Canning MD Exstrophy Database Center, Charlotte Bloomberg Children's Hospital, The Johns Hopkins Medical Institutions, Baltimore, MD. Electronic address:
Objective: To identify risk factors for stenosis and compare management strategies for stenosis etiology and to examine the efficacy of each approach. Patients with classic bladder exstrophy (CBE), a rare genitourinary malformation, may require construction of a continent urinary stoma (CUS) if incontinence persists. Stomal stenosis is a challenging complication as it is common, progressive, and recurrent.
View Article and Find Full Text PDFAnn Acad Med Singap
February 2024
National Skin Centre, Singapore.
Ribonucleic acid (RNA) therapeutics hold great potential for the advancement of dermatological treatments due to, among other reasons, the possibility of treating previously undruggable targets, high specificity with minimal side effects, and ability to include multiple RNA targets in a single product. Although there have been research relating to RNA therapeutics for decades, there have not been many products translated for clinical use until recently. This may be because of challenges to the application of RNA therapeutics, including the dearth of effective modes of delivery to the target, and rapid degradation of RNA in the human body and environment.
View Article and Find Full Text PDFClin Cosmet Investig Dermatol
June 2024
Department of Research, Scar Healing Institute, Los Angeles, CA, USA.
Hypertrophic and keloid scars are fibroproliferative growths resulting from aberrant wound healing. Individuals with Fitzpatrick skin types (FSTs) IV-VI are particularly predisposed to hypertrophic and keloid scarring, yet specific guidelines for these populations are still lacking within the literature. Therefore, this comprehensive review provides a list of various treatments and considerations for hypertrophic and keloid scarring in patients with skin of color.
View Article and Find Full Text PDFJ Cosmet Dermatol
October 2024
Division of Dermatology, Department of Internal Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Background: Botulinum toxin A (BoNT-A) is widely utilized in the management of hypertrophic and keloid scars. One proposed mechanism for scar prevention involves the inhibition of fibroblast migration in scars by BoNT-A. However, the data regarding the effect of BoNT-A on the migration of normal human dermal fibroblasts (NHDF) is limited.
View Article and Find Full Text PDFCell Commun Signal
June 2024
Department of Plastic and Reconstructive Surgery, The First Medical Centre, Chinese PLA General Hospital, 28 Fuxing Street, Beijing, 100853, China.
Excessive scar formation such as hypertrophic scars and keloids, resulting from trauma or surgical procedures, present a widespread concern for causing disfigurement, discomfort, and functional limitations. Macrophages play pivotal roles in maintaining tissue homeostasis, orchestrating tissue development, repair, and immune responses, and its transition of function and phenotype plays a critical role in regulating the balance between inflammation and tissue regeneration, which is central to cutaneous scar formation. Recent evidence suggests the involvement of Sonic Hedgehog (SHH) in the induction of anti-inflammatory M2-like macrophage phenotypes within tumor microenvironments.
View Article and Find Full Text PDFArch Dermatol Res
June 2024
MRC-SA Wound Healing and Keloid Research Unit, Division of Dermatology, Department of Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa.
Keloid scars and folliculitis keloidalis nuchae (FKN) are benign fibroproliferative dermal lesions of unknown aetiology and ill-defined treatment, which typically present in genetically susceptible individuals. Their pathognomonic hallmarks include local aggressive invasive behaviour plus high recurrence post-therapy. In view of this, we investigated proliferative and key parameters of bioenergetic cellular characteristics of site-specific keloid-derived fibroblasts (intra(centre)- and peri(margin)-lesional) and FKN compared to normal skin and normal flat non-hypertrophic scar fibroblasts as negative controls.
View Article and Find Full Text PDF